In clinical trials, individuals are matched using demographic criteria, paired and then randomly assigned to treatment and control groups to determine a drugs efficacy. A chief cause for the irreproducibility of results across pilot to Phase-III trials is population stratification bias caused by the uneven distribution of ancestries in the treatment and control groups.